Anti Factor Xa
Additional Codes
LAB5416
Performing Laboratory
MBMC Main Laboratory
Methodology
Chromogenic Assay
Literature References:
Package insert: HemosIL Liquid Anti Xa, Instrumentation Laboratory, November 2011
Specimen Requirements
Call Missouri Baptist Medical Center Laboratory Customer Support at 314-996-4522 prior to collection.
Specimen must arrive and be tested within 4 hours of draw.
Specimen Type: Plasma
Container/Tube: 2.7-mL, light blue-top (sodium citrate) tube
Specimen Volume: Full tube
Collection Instructions: If unable to send STAT, spin down, separate plasma from cells, and freeze.
Specimen Transport Temperature
Ambient <4 hours/Frozen OK
Day(s) Test Set Up
Monday through Sunday
Turnaround Time:
STAT: 1 hour from receipt in laboratory
Reference Values
Anti-Xa Interpretive Data
Enoxaparin therapeutic range (peak):
VTE treatment, Q12hr dosing: 0.60-1.00 IUnits/mL
VTE treatment, Q24hr dosing: 1.00-2.00 IUnits/mL
Q24hr dosing for renal impairment (CrCl <30 mL/min): 0.60-1.00 IUnits/mL
VTE prevention: 0.10-0.40 IUnits/mL
Anti-Xa therapeutic ranges apply to blood samples drawn 4 hours after last dose (peak).
Unfractionated heparin (UFH) therapeutic range: 0.30-0.70 IUnits/mL
Direct factor Xa inhibitors (rivaroxaban, apixaban): Results must be interpreted qualitatively. No activity detected suggests little anticoagulant activity.
In severe antithrombin deficiency, anti-Xa measurement may be inaccurate.
Interpretive guidelines developed in adult populations. Interpretive guidelines for pediatric patients have not been rigorously defined.
Alert Value: >2.00 I U/mL
Test Classification and CPT Coding
Test Classification:
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer’s instructions.
CPT Code:
85520
Stability
4 hours Ambiant temperature